Programme - Thursday March 24th - CET time zone
Available Channels
1
2
01:00 - 23:59
WCO-IOF-ESCEO
13:30 - 15:15
Scientific Session I
Chairpersons:
René Rizzoli
& Cyrus Cooper
1
Channel
13:30
Best clinical papers published in 2021
1
Channel
14:10
Opening of the meeting
1
Channel
14:25
Award Presentation
Presentation of the ESCEO-Islene Araujo de Carvalho Grant
1
Channel
14:35
Award Presentation
Presentation of the IOF CSA Medal of Achievement, the IOF Skeletal Rare Disease Academy Awards, the IOF Nutrition Awards
1
Channel
14:40
Awards Presentation
Presentation of the IOF Olof Johnell Science Award, the IOF President’s Award and the ESCEO-IOF Herbert Fleisch Medal
1
Channel
14:45
Plenary Lecture 1
Can we expect new chemical entities for the management of osteoporosis in the coming years
15:30 - 17:00
Scientific Session II
Chairpersons:
Nicholas Harvey
& Teréza Hough
1
Channel
15:30
Plenary Lecture 2
Update of the management of patients at imminent fracture risk
1
Channel
16:00
Meet-The-Expert Session
Role of biochemical assessments in the management of osteoporosis
1
Channel
16:30
Meet-The-Expert Session
German guidelines for the management of post-menopausal osteoporosis
17:00 - 18:30
1
Channel
Sponsored Satellite Symposium
Programme - Friday March 25th - CET time zone
Available Channels
1
2
08:15 - 09:15
1
Channel
Sponsored Satellite Symposium
08:15 - 09:15
2
Channel
ESCEO SYMPOSIUM
Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patients expectancies
Chairpersons:
Cyrus Cooper
& Olivier Bruyère
- Introduction: Why do we need a multimodal multidisciplinary management of osteoarthritis
- Multimodal multicomponent approach using oral medications
- Multimodal multicomponent approach combining injectable and oral medications
- Conclusion
09:15 - 11:45
Scientific Session III
Chairpersons:
Jean-Yves Reginster
& Elaine Dennison
1
Channel
09:15
Meet-The-Expert Session
Which drugs do impact fracture healing?
1
Channel
09:45
Plenary Lecture 3
Added value of the new version of the FRAX® algorithm
1
Channel
10:15
Meet-The-Expert Session
Treatment of disorders of phosphate homeostasis
1
Channel
10:45
Plenary Lecture 4
Cross-talking between the immune system and the skeleton
1
Channel
11:15
Plenary Lecture 5
How long should we treat osteoporotic patients under sequential therapy?
09:15 - 10:15
2
Channel
IOF Educational Lecture
Challenges and opportunities in the bone field, an IOF perspective
12:00 - 13:30
1
Channel
Sponsored Satellite Symposium
12:00 - 13:30
2
Channel
Sponsored Satellite Symposium
13:30 - 16:00
Scientific Session IV
Chairpersons:
Claudia Campusano
& John A. Kanis
1
Channel
13:30
Plenary Lecture 6
Calcium or vitamin D: both or neither?
1
Channel
14:00
Meet-The-Expert Session
Assessment of quality of life in sarcopenia: an urgent issue
1
Channel
14:30
Meet-The-Expert Session
Role of registries in musculoskeletal management
1
Channel
15:00
Sponsored Meet-The-Expert Session
13:30 - 17:40
Scientific Session V
Chairpersons:
Stefania Maggi
& Andreas Kurth
2
Channel
13:30
Educational Lecture
- Post-fracture care: State of the Art?
2
Channel
14:20
Oral communication selected from abstracts
OC1: COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POST-MENOPAUSAL WOMEN NEW TO ANABOLIC THERAPY: A US REAL-WORLD DATABASE STUDY
Presenting author:
Authors:
2
Channel
14:30
Oral communication selected from abstracts
OC2: USE OF ROMOSOZUMAB IN THOSE WHO EXPERIENCED AN ON-STUDY FRACTURE: RESULTS FROM THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS
Presenting author:
Authors:
2
Channel
14:40
Oral communication selected from abstracts
OC3: CONCOMITANT PPI USE NEGATES ORAL BISPHOSPHONATE ANTI-FRACTURE EFFICACY: A POST HOC ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL OF CLODRONATE
Presenting author:
Authors:
2
Channel
14:50
Oral communication selected from abstracts
OC4: FRACTURE RISK IN WOMEN WITH OSTEOPOROSIS TREATED WITH GASTRO-RESISTANT RISEDRONATE VERSUS IMMEDIATE RELEASE RISEDRONATE OR ALENDRONATE: A CLAIMS DATA ANALYSIS IN THE UNITED STATES
Presenting author:
Authors:
2
Channel
15:00
Sponsored Meet-The-Expert Session
2
Channel
16:00
Oral communication selected from abstracts
OC5: FRACTURES INCREASE EARLY AND LONG-TERM MORTALITY IN CANCER PATIENTS: A POPULATION-BASED COHORT STUDY
Presenting author:
Authors:
2
Channel
16:10
Oral communication selected from abstracts
OC6: IMPROVED FRACTURE RISK PREDICTION BY ADDING VFA-IDENTIFIED VERTEBRAL FRACTURE DATA TO BMD BY DXA AND CLINICAL RISK FACTORS USED IN FRAX
Presenting author:
Authors:
2
Channel
16:20
Oral communication selected from abstracts
OC7: MACHINE LEARNING AND COMPUTER VISION OF BONE MICROARCHITECTURE CAN IMPROVE THE FRACTURE RISK PREDICTION PROVIDED BY DXA AND CLINICAL RISK FACTORS
Presenting author:
Authors:
2
Channel
16:30
Oral communication selected from abstracts
OC8: PRIMARY HYPERPARATHYROIDISM, BONE MINERAL DENSITY AND INCIDENT FRACTURE RISK: A DANISH REGISTER STUDY
Presenting author:
Authors:
2
Channel
16:40
Meet-The-Expert Session
Management of tumoral bone disease
2
Channel
17:10
Oral communication selected from abstracts
OC9: VERTEBRAL FRACTURES ON ROUTINE CT SCANS PREDICT MAJOR OSTEOPOROTIC FRACTURES AND HIP FRACTURES: OBSERVATIONAL COHORT STUDY
Presenting author:
Authors:
2
Channel
17:20
Oral communication selected from abstracts
OC10: THE PROPORTION OF PATIENTS WHO REACH THE BMD SURROGATE THRESHOLD EFFECT ON ROMOSOZUMAB: A POST HOC ANALYSIS OF THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS
Presenting author:
Authors:
2
Channel
17:30
Oral communication selected from abstracts
OC11: RISK OF FALLS AND FRACTURES FOLLOWING THE INITIATION OF ANTI-HYPERTENSIVES IN THE ELDERLY: SELF-CONTROLLED CASE SERIES ANALYSES FROM THE UK
Presenting author:
Authors:
16:00 - 17:45
Scientific Session VI
Chairpersons:
Olivier Bruyère
& Patricia Clark
1
Channel
16:00
Plenary Lecture 7
Skeletal and extraskeletal effects of FGF23
1
Channel
16:30
Sponsored Meet-The-Expert Session
1
Channel
17:30
Awards Presentation
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award, the 2022 ESCEO Medal of Excellence
1
Channel
17:35
Award Presentation
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
1
Channel
17:40
Presentation of the ESCEO-IOF Young Investigator Awards
Programme - Saturday March 26th - CET time zone
Available Channels
1
2
09:00 - 12:00
Scientific Session VII
Chairpersons:
Manju Chandran
& Emmanuel Biver
1
Channel
09:00
Plenary Lecture 8
How to treat bone fragility in chronic kidney disease
1
Channel
09:30
Meet-The-Expert Session
Assessment and management of primary hyperparathyroidism
1
Channel
10:00
Meet-The-Expert Session
Cardio-vascular effects of bisphosphonates
1
Channel
10:30
Meet-The-Expert Session
Development of fracture prevention services in low- and middle-income countries
1
Channel
11:00
Meet-The-Expert Session
Management of osteoarthritis in 2022: How to reconciliate divergent guidelines
1
Channel
11:30
Meet-The-Expert Session
Pharmacological and non-pharmacological management of patients following hip fracture
09:30 - 11:20
Scientific Session VIII
Chairpersons:
Martina Rauner
& Etienne Cavalier
2
Channel
09:30
Oral communication selected from abstracts
OC12: MISALIGNMENT BY PRODUCING INEFFECTIVE LOAD CONDUCTION (TRANSFER) MAY BE RESPONSIBLE FOR ATYPICAL FEMORAL FRACTURES (AFFS)
Presenting author:
Authors:
2
Channel
09:40
Oral communication selected from abstracts
OC13: BONE MINERAL DENSITY AND BONE MICRO-ARCHITECTURE EVOLUTION AFTER KIDNEY TRANSPLANTATION: 3-MONTHS RESULTS OF A PROSPECTIVE COHORT STUDY
Presenting author:
Authors:
2
Channel
09:50
Oral communication selected from abstracts
OC14: HEALTHCARE EXPENDITURE IN FRAGILITY FRACTURE PATIENTS ACROSS 10 COUNTRIES: A MICRO-COSTING STUDY
Presenting author:
Authors:
2
Channel
10:00
Meet-The-Expert Session
The Use of Bisphosphonates to Manage Muscle Wasting
2
Channel
10:30
Oral communication selected from abstracts
OC15: GENETICS OF ATYPICAL FEMUR FRACTURES
Presenting author:
Authors:
2
Channel
10:40
Oral communication selected from abstracts
OC16: ASSOCIATIONS OF CALCIUM INTAKE AND CALCIUM SOURCES WITH BLOOD LIPIDS IN A POPULATION OF OLDER WOMEN AND MEN WITH HIGH CALCIUM INTAKE
Presenting author:
Authors:
2
Channel
10:50
Oral communication selected from abstracts
OC17: PRUNES PRESERVE HIP BONE MINERAL DENSITY AND FRAX RISK IN A 12-MONTH RANDOMIZED CONTROLLED TRIAL IN POSTMENOPAUSAL WOMEN: THE PRUNE STUDY
Presenting author:
Authors:
2
Channel
11:00
Oral communication selected from abstracts
OC18: PREVALENCE OF OSTEOPOROSIS AND OSTEOPENIA IN MEN AND WOMEN FROM SUB-SAHARAN AFRICA, THE UK AND US: A GLOBAL PROBLEM
Presenting author:
Authors:
2
Channel
11:10
Oral communication selected from abstracts
OC19: GENETIC BIOMARKERS, SNP GENES AND MTDNA HAPLOGROUPS, PREDICT OSTEOARTHRITIS STRUCTURAL PROGRESSORS THROUGH THE USE OF SUPERVISED MACHINE LEARNING
Presenting author:
Authors:
11:20 - 14:10
Scientific Session IX
Chairpersons:
Famida Jiwa
& Mickaël Hiligsmann
2
Channel
11:20
Oral communication selected from abstracts
OC20: EROSIVE OSTEOARTHRITIS OF THE HAND: EFFICACY OF PRESCRIPTION-GRADE CRYSTALLINE GLUCOSAMINE SULFATE AS AN ADD-ON THERAPY TO CONVENTIONAL TREATMENTS
Presenting author:
Authors:
2
Channel
11:30
Oral communication selected from abstracts
OC21: HEALTH ECONOMICS EVALUATION OF A HIGH AND LOW MOLECULAR WEIGHT HYALURONIC ACID FORMULATION IN PATIENTS WITH KNEE OSTEOARTHRITIS. ANALYSES FROM A RANDOMIZED CLINICAL TRIAL
Presenting author:
Authors:
2
Channel
11:40
Oral communication selected from abstracts
OC22: LOWER LIMB MUSCLE STRENGTH AND MUSCLE MASS ARE ASSOCIATED WITH INCIDENT SYMPTOMATIC KNEE OSTEOARTHRITIS: A LONGITUDINAL COHORT STUDY
Presenting author:
Authors:
2
Channel
11:50
Oral communication selected from abstracts
OC23: DOES LOW MUSCLE STRENGTH MODIFY RELATIONSHIPS BETWEEN INDIVIDUAL COMORBIDITIES AND MORTALITY? FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
2
Channel
12:00
Oral communication selected from abstracts
OC24: THE LONGITUDINAL ASSOCIATIONS OF SARCOPENIA DEFINITIONS WITH ADVERSE OUTCOMES: A COMPARATIVE STUDY
Presenting author:
Authors:
2
Channel
12:10
Educational Lecture
- How can artificial intelligence impact the management of musculoskeletal diseases
2
Channel
13:00
Oral communication selected from abstracts
OC25: WHAT ARE THE MAIN RISK FACTORS FOR LOWER EXTREMITY RUNNING-RELATED INJURIES? A RETROSPECTIVE SURVEY BASED ON 3669 RESPONDENTS
Presenting author:
Authors:
2
Channel
13:10
Oral communication selected from abstracts
OC26: WHAT IMPACT HAS THE COVID-19 PANDEMIC HAD ON LIFESTYLE FACTORS IMPORTANT TO MUSCULOSKELETAL HEALTH? RESULTS FROM TWO COHORT STUDIES
Presenting author:
Authors:
2
Channel
13:20
Oral communication selected from abstracts
OC27: GERAS FRAILTY REHABILITATION AT HOME RANDOMIZED CONTROLLED TRIAL: VIRTUAL BUNDLED CARE FOR SENIORS WHO ARE FRAIL TO BUILD STRENGTH AND RESILIENCE DURING COVID-19
Presenting author:
Authors:
2
Channel
13:30
Oral communication selected from abstracts
OC28: THE ASSOCIATION BETWEEN SOCIAL ISOLATION AND LONELINESS AND SARCOPENIA AND OSTEOPOROSIS AMONG OLDER ADULTS: RESULTS FROM THE CANADIAN LONGITUDINAL STUDY ON AGING (CLSA)
Presenting author:
Authors:
2
Channel
13:40
Meet-The-Expert Session
- Managing your FLS/PFC center more efficiently and cost optimized with Lyosis Software
12:30 - 14:30
Scientific Session X
Chairpersons:
Radmila Matijevic
& Roland Chapurlat
1
Channel
12:30
Plenary Lecture 9
Muscle and joint: Sarcopenia and Osteoarthritis
1
Channel
13:00
Sponsored Meet-The-Expert Session
1
Channel
14:00
Meet-The-Expert Session
Fall prevention strategies
14:30 - 15:30
Scientific Session XI
Chairpersons:
Friederike Thomasius
& Peyman Hadji
1
Channel
14:30
Plenary Lecture 10
Health Economics in osteoporosis : which model for which assessment
1
Channel
15:00
Meet-The-Expert Session
Hormonal contraception and bone health